Development of experimental GBS vaccine for mucosal immunization

Streptococcus agalactiae, or group B streptococcus (GBS), is an important pathogen as it is the leading cause of neonatal deaths due to sepsis, meningitis or bacterial pneumonia. Although the development of an effective and safe GBS vaccine is on the agenda of many research labs, there is no GBS vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupalova, T., Leontieva, G., Kramskaya, T., Grabovskaya, K., Bormotova, E., Korjevski, D., Suvorov, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935385/
https://www.ncbi.nlm.nih.gov/pubmed/29727446
http://dx.doi.org/10.1371/journal.pone.0196564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935385/
https://www.ncbi.nlm.nih.gov/pubmed/29727446
http://dx.doi.org/10.1371/journal.pone.0196564

Ejemplares similares